#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    IPEX syndrome Thrombotic microangiopathy Vulval cancer recurrent Hyperinsulinism Gastrointestinal neuroendocrine tumour Allogenic stem cell transplantation Ovarian epithelial cancer Acute promyelocytic leukaemia Metabolic disorder Hairy cell leukaemia recurrent Sexually transmitted disease Skin cancer Pericarditis Angiosarcoma Prostate cancer More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Trials in Disease Mantle cell lymphoma stage II – Trials in Disease Mucopolysaccharidosis III – Basic Information Biotinidase deficiency Haemolytic uraemic syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Diagnostics Nodal marginal zone B-cell lymphoma – Life with Disease Glomerulonephritis membranous – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Flucloxacillin HYDROGEN VTX-002 SODIUM HYDROXIDE Amantadine Hemisulfate Mitoxantrone Hydrochloride Setanaxib Balstilimab Sorafenib Tosilate Cedazuridine H2-Receptor Antagonists Pegcetacoplan Jnj-77242113 Sodium Iodide (131I) Afm24 Loratadine Inotuzumab Ozogamicin [18F]-Altanserin Navtemadlin Zilovertamab Vedotin More therapies…

    Learn about Your Condition

    Neuropathy peripheral Menopausal symptoms White matter lesion Neurofibrosarcoma Medullary thyroid cancer Erectile dysfunction Brain stem glioma Drug eruption Von Willebrand's disease Thrombotic microangiopathy Juvenile idiopathic arthritis Glioma Pulmonary sarcoidosis Lung disorder Dilated cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis

    Recruiting

    3 1
    Investigated Drugs:
    • Iptacopan
    Denmark France Germany Greece Italy The Netherlands +3

  • Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated Drugs:
    • 2-Amino-9-((2R,4R,5R)-4-Hydroxy-5-(Hydroxymethyl) Tetrahydrofuran-2-Yl)-1,4,5,9-Tetrahydro-6H-Purine-6-Thione
    • Cemiplimab
    Bulgaria Hungary Poland Romania

  • Study on Preventing C. difficile Infections with Oral Vancomycin in Patients Undergoing Allogeneic Stem Cell Transplantation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Vancomycin
    France

  • Study on BP1.7881 for Adults with Eosinophilic Esophagitis

    Recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Bp1.7881A
    France Italy

  • Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Amoxicillin Sodium
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    Belgium Croatia Czechia Denmark Greece Italy +2

  • Study on the Effects of Ramipril, Bisoprolol, and Dapagliflozin in Patients with ST-Elevation Myocardial Infarction (Heart Attack)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Ramipril
    • Bisoprolol
    • Dapagliflozin
    Sweden
Previous Page
1 … 512 513 514 515 516 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!